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The tumor suppressor WT1 has been demonstrated to have a wide variety of activities in vitro and is required for
metanephric development in vivo. In the experiments presented here, the Xenopus pronephros was used as a simple model
system to examine the activity of Xenopus WT1 (xWT1) during kidney development. xWT1 was ectopically expressed in
Xenopus embryos by mRNA injection and found to inhibit pronephric tubule development. Confocal microscopy confirmed
this observation and revealed that the inhibition was the result of a failure to form a pronephric anlage of appropriate size
rather than a defect in epithelialization. Examination of Xlim-1 expression, an early molecular marker of pronephric
specification, in tailbud embryos indicated that injected xWT1 mRNA inhibited pronephric specification prior to any overt
sign of morphogenesis (Xenopus stage 21). These results suggest that xWT1 may act to repress tubule-specific gene
expression in the portion of the pronephros fated to form its vascular structure, the glomus. © 1998 Academic Press
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INTRODUCTION
Embryos form and utilize different kidney types at differ-
ent stages of development. In the higher vertebrates, a pair
of embryonic mesonephroi control water and salt balance
during early development, and this function is later relin-
quished to a pair of metanephroi, the adult kidneys. In
lower vertebrates, such as fish and amphibians, the meso-
nephroi are in fact the adult kidneys, and embryonic water
balance is maintained by a pair of much simpler organs, the
pronephroi (Mu¨ller, 1829; Burns, 1955; Saxe´n, 1987; Vize et
al., 1997). Each pronephros is organized in a manner similar
to that of a single metanephric nephron, with a filtration
apparatus (the glomus), a simple set of tubules for the
collection of filtrate and resorption of nutrients (the pro-
nephric tubules), and an excretory duct (pronephric or
Wolffian duct) for the disposal of wastes (Field, 1891; Fox,
1963; Balinsky, 1970; Vize et al., 1995; Carroll and Vize,
1996). The simple architecture of the pronephroi, as well as
their amenability to experimental manipulation and obser-
vation, make the amphibian embryo an excellent system in
which to study organogenesis of the kidney. Interestingly,
several recent experiments demonstrate that many of the
same genes are expressed during organogenesis of pro-,
meso-, and metanephroi, suggesting that conserved genetic
pathways may be used in the development of all three forms
of this organ (reviewed by Vize et al., 1997).
The tumor suppressor gene WT1 is expressed in the
developing mammalian nephric system (Pelletier et al.,
1991a; Armstrong et al., 1992; Mundlos et al., 1993), and in
mice lacking WT1, the metanephric blastema degenerates
early in development, and kidneys do not form (Kreidberg et
al., 1993). These results suggest a critical role for WT1 in
the development of the metanephric tubules. In the later
stages of nephrogenesis, WT1 expression is restricted to the
podocytes of the Bowman’s capsule, the vascularized com-
ponent of mammalian nephrons (Pelletier et al., 1991a;
Armstrong et al., 1992; Mundlos et al., 1993), and humans
with mutations in WT1 often suffer from glomerular ne-
phropathy, a failure of kidney vascular development (Pelle-
tier et al., 1991b). These results suggest a role for WT1 in
the development of the vascular component of the kidney
in addition to the early role in mesenchymal condensation.
Such a role in the development of the vascular component
of the kidney is supported by the observation that expres-
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sion of the Xenopus ortholog of WT1 (xWT1) is restricted to
the vascularized glomus throughout pronephric develop-
ment (Carroll and Vize, 1996).
WT1 encodes a zinc-finger type transcription factor, and
mutations in WT1 have been identified in Wilms’ tumors,
pediatric tumors of the kidney (reviewed by Coppes et al.,
1995). In vitro, WT1 is a powerful suppressor of transcrip-
tion from several promoters, including Pax2, IGF II, the
EGF receptor, and the PDGF a-chain, genes that have been
implicated in the regulation of kidney development (Mad-
den et al., 1991; Ryan et al., 1995; Drummond et al., 1992;
Englert et al., 1995; Wang et al., 1995). WT1 also contains
an RNA recognition motif and may regulate gene activity
posttranscriptionally by binding mRNA (Kennedy et al.,
1996; Caricasole et al., 1996; Larsson et al., 1995). Despite
of the wealth of data concerning WT1 activity, its precise
role in the development of the kidney has yet to be
determined.
In this report, the Xenopus pronephros was utilized as a
simple kidney model system in which to examine the
activity of xWT1 in vivo. xWT1 was ectopically expressed
in Xenopus embryos by mRNA injection and found to
inhibit pronephric development prior to the first signs of
morphogenesis at stage 21 (Nieuwkoop and Faber, 1994).
The inhibitory action of xWT1 on pronephric tubule devel-
opment suggests a role for WT1 genes in the downregula-
tion of the response to inductive signals during nephrogen-
esis. This activity and the expression patterns of WT1 and
xWT1 further suggest that this gene plays a similar role in
the development of the vascular components of both pro-
nephroi and metanephroi: inhibiting the expression of
tubule-specific genes in cells which will form the vascular
component of the kidney.
MATERIALS AND METHODS
DNA constructs. The xWT1-KTS coding region was released
from pGEMxWT1 (Carroll and Vize, 1996) with BamH1 and
subcloned into the BglII site of pSP64TS to generate p64TSxWT1-
KTS. pSP64TS is a modified form of pSP64T (Krieg and Melton,
1984) and contains a polylinker with two additional cloning sites
(EcoRV and SpeI) following the existing BglII site, followed by
translation termination codons in all three reading frames.
pSP64TS provides in vitro transcribed mRNAs with Xenopus
globin 59 and 39 untranslated regions and greatly increases the
amount of protein translated (Krieg and Melton, 1984). To con-
struct the 1KTS expression plasmid, the coding region of xWT23
(Carroll and Vize, 1996) was amplified by PCR using primers with
BamHI ends and cloned into the BglII site of pSP64TS. The
resulting intermediate clone was digested with ApoI to release the
39 half of xWT1 1 KTS as well as about 300 bp of pSP64TS 39 to the
xWT1 insert. p64TSxWT1-KTS was similarly digested with ApoI,
and the 1KTS 39 half of xWT1 from the intermediate plasmid was
inserted, producing p64TSxWT1 1 KTS.
Embryos and microinjection. Female adult Xenopus were in-
duced to ovulate with human chorionic gonadotropin, and eggs
were fertilized in vitro according to Peng et al. (1991). Embryos
were dejellied in 3% cysteine solution and washed in 0.23 MMR.
Embryos were then reared at 13–18°C in 0.23 MMR. Microinjec-
tions were performed as previously described (Vize et al., 1991).
Capped mRNA was produced by in vitro transcription (Krieg and
Melton, 1984). To minimize nonspecific toxicity effects, mRNA
was purified using a Sephadex G-50 column. In vitro transcriptions
were also treated with DNase1 prior to mRNA Sephadex purifica-
tion to minimize the amount of DNA injected. Purified mRNAs
were resuspended in sterile water for injections. All mRNAs were
translated in vitro and generated proteins of appropriate size,
indicating that all mRNAs were functional.
The volume of each injection was 5 nl, and the dosage was varied
by altering the concentration of the mRNA injected. Injections
were made at the 16- to 64-cell stages into the presumptive
pronephric region (blastomeres C3 and D3 at the 32-cell stage) or
the presumptive somite (blastomeres C2 and C3 at the 32-cell
stage) according to the fate map of Dale and Slack (1987). In all
cases 0.25 ng of b-galactosidase mRNA was co-injected as a lineage
tracer for the injected xWT1 mRNA (Vize et al., 1991).
RT-PCR. Embryos were injected at the 32-cell stage, and their
development was stopped at stages noted in the text and figure
legends. RNA was purified from these staged samples. To ensure
that this analysis detected only the injected mRNA and not
injected plasmid DNA, all samples were treated with DNaseI prior
to RT–PCR. RT–PCR was performed according to Carroll and Vize
(1996). cDNA was synthesized using two primers: oligo(dT) and a
primer homologous to the extreme 39 end of the Xenopus b-globin
39 untranslated region (59 GGAGCAGATACGAAT 39). The second
primer was included in case the short poly(A) tail contained within
the transcribed region was insufficient for priming by oligo(dT)
(Krieg and Melton, 1984). Two primer sets were used for PCR
amplification of this cDNA. The first amplified the injected xWT1
mRNA specifically by using a 59 primer (59 CACACSCAC-
GGGGTCT 39) homologous to xWT1 and a 39 primer homologous
to the Xenopus b-globin 39 untranslated region (59 GACTCCAT-
TCGGGTG 39). The second set amplified endogenous EF-1a
mRNA as a control for RNA recovery and RT–PCR efficacy (59
CAGATTGGTGCTGGATATGC 39 and 59 ACTGCCTTGAT-
GACTCCTAG 39). Negative control reactions omitting reverse
transcriptase were performed on the first and last samples in the
series; positive controls were performed using 1 ng of
pSP64TSxWT1-KTS plasmid DNA. Twenty-five cycles of amplifi-
cation of injected xWT1-b-globin fusion mRNA and 19 cycles of
amplification of endogenous EF-1a mRNA were performed using
0.5 embryo equivalents of cDNA.
Immunohistochemistry. Embryos were fixed in MEMFA for 30
min and then washed in 13 PBS. b-Galactosidase activity was
detected according to Vize et al. (1991), and embryos were then
washed in PBS, refixed for 30 min in MEMFA, washed in TBST,
dehydrated overnight in methanol at 4°C, rehydrated in TBST, and
blocked with 20% horse serum, 0.1 mg/ml BSA, and TBST.
Embryos were incubated in primary antibody overnight at 4°C and
then washed 6 3 1 h in TBST, blocked again, incubated in alkaline
phosphatase-conjugated secondary antibody overnight, washed 6 3
1 h in TBST, and stained for alkaline phosphatase using NBT/BCIP
(Boehringer-Mannheim) or Histomark Red (Kirkegard and Perry)
(see Vize et al., 1995). Antibody 3G8 was used to detect pronephric
tubules (Vize et al., 1995); antibody 12/101 was used to detect
somite (Kintner and Brockes, 1984).
In situ hybridization. Embryos were fixed, stained for
b-galactosidase, and refixed as described above. In situ hybridiza-
tion was then carried out according to the procedure of Harland
(1991).
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Confocal microscopy. Embryos were fixed in MEMFA for 1 h
and washed in TBST, dehydrated overnight in methanol at 4°C, and
rehydrated in TBST. Antibody 3G8 and a rhodamine-coupled
secondary were applied as described above except that after wash-
ing out excess secondary antibody, embryos were dehydrated in an
ethanol series and cleared for confocal viewing in 2:1 benzyl
benzoate:benzyl alcohol. Embryos were viewed using a rhodamine
GHS filter set, and images were collected using a Bio-Rad MRC-500
confocal scanning laser microscope. For nuclear staining, embryos
were rehydrated in TBST and incubated in 5 mg/ml propidium
iodide for 1 h, washed in TBST, and prepared for confocal viewing
as above.
RESULTS
The Pronephric Index (PNI)
In order to facilitate studies of early kidney development,
a simple index (defined in the legend to Fig. 1) was designed
to quantify the extent of pronephric tubule development.
The pronephros is a dynamic structure in the developing
tadpole, so slight differences between the two pronephroi
within an embryo are not uncommon; however, significant
differences are very rare (Vize et al., 1995; Fox, 1963). After
observing hundreds of uninjected control embryos, a PNI of
greater than 2 (for calculation, see Fig. 1) was determined to
indicate a disparity in pronephric development not attrib-
utable to normal variation. Indeed, less than 1% of unin-
jected embryos display such differences between the two
pronephroi (Table 1). Therefore, experimental perturbations
can be made on one side of the embryo and the opposite side
can act as an internal control for the degree of pronephric
development in each embryo examined.
Injection of mRNA into Xenopus embryos has been
demonstrated to be a very effective method for analyzing
gene function (Vize et al., 1991). b-Galactosidase mRNA
was injected at a range of concentrations to control for the
possibility that any observed pronephric phenotype follow-
ing mRNA injection may be the result of injection trauma
or nonspecific mRNA toxicity. Injections were made into
the C3 and D3 blastomeres on one side of 32-cell stage
embryos, as these blastomeres are fated to contribute to the
pronephros (Dale and Slack, 1987). Detection of b-galact-
osidase activity indicated that injections into these blas-
tomeres targeted the mRNA to the pronephric region of the
tadpole (Fig. 1B). Analysis of pronephric tubule develop-
ment with the pronephric tubule-specific antibody 3G8
(Vize et al., 1995) demonstrated that injection of doses
ranging from 0.25 to 2 ng of b-galactosidase mRNA consis-
tently had no effect on pronephric development (Table 1,
Fig. 1, and data not shown).
Overexpression of xWT1 Inhibits Pronephric
Tubule Development
In order to examine the activity of the xWT1 gene in vivo,
mRNA encoding xWT1 (Carroll and Vize, 1996) was micro-
injected into Xenopus embryos which were then reared to
tadpole stages and analyzed for pronephric development
by immunohistochemistry with the pronephric tubule-
specific antibody 3G8. Injections were made on one side at
the 32-cell stage into the C3 and D3 blastomeres, which are
fated to contribute to the pronephros (Fig. 1; Dale and Slack,
1987). All embryos were co-injected with xWT1 mRNA as
well as 0.25 ng of b-galactosidase mRNA as a lineage tracer
in order to ensure that all analyzed embryos did express
exogenous xWT1 mRNA in the pronephros. Only embryos
in which b-galactosidase activity was detected in the region
of the pronephros were scored for pronephric phenotypes.
While pronephroi developed normally on the uninjected
sides of experimental embryos in all cases (Figs. 2A and 2C),
injection of xWT1 mRNA strongly suppressed pronephric
tubule development on the injected side (Figs. 2B and 2D).
In mild cases, tubules formed in injected pronephroi, but
the tubule diameter and length were noticeably reduced
(Fig. 2B). In many instances, the distal branches of the
collecting tubules were absent (Figs. 2B and 2b9). In more
severe cases, only a single, small, unbranched tubule was
present on the injected side (Figs. 2D and 2d9). In extreme
cases, there was no sign of tubule staining whatsoever on
the injected side of the embryo (not shown). Ectopic expres-
sion of either splice form of xWT1 elicited identical pheno-
types, although xWT1 1 KTS (Carroll and Vize, 1996) did so
at a slightly lower frequency (Table 1 and data not shown).
Several other mRNAs were injected into the presumptive
pronephric region as controls to ensure that the small
pronephroi were not due to a general mRNA toxicity
problem. As mentioned above, injection of b-galactosidase
mRNA had no effect on the development of the pronephros
(Fig. 1, Table 1). Several genes involved in kidney develop-
ment were also overexpressed by mRNA injection, includ-
ing Xlim-1 (Taira et al., 1995), xHGF (Nakamura et al.,
1995), and XPax-2 (Heller and Brandli, 1997); none of these
injections inhibited pronephric development (data not
shown).
TABLE 1
Frequency of xWT1-Induced Inhibition of Pronephric
Tubule Development
Injected RNA % Embryos PNI . 2 N
None 0.7 2/270
b-Galactosidase 1.5 1/66
xWT1-KTS 34.0 36/106
xWT11KTS 21.0 8/38
Note. Embryos were injected on one side at the 32-cell stage with
the mRNA’s as indicated, reared to tadpole stages, fixed, analyzed
for b-galactosidase expression, and assayed for pronephric tubule
development with antibody 3G8. Only embryos with b-galact-
osidase expression in the pronephric region were scored. Proneph-
ric tubule development was quantified according to the pronephric
index defined in the text and in the legend to Fig. 1. A portion of the
embryos were injected independently in another lab and scored
blind in our lab.
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It was possible that xWT1 was acting as a nonspecific
inhibitor of differentiation. To address this issue, xWT1-
KTS mRNA was injected into cells fated to contribute the
somites (blastomere C2; Dale and Slack, 1987). Expression
of xWT1 resulted in no significant increase in somite
defects over controls when assayed by immunohistochem-
istry with somite-specific antibodies (data not shown),
indicating that xWT1 is not a general inhibitor of differen-
tiation.
Confocal Microscopic Analysis of xWT1
Overexpression Phenotype
The pronephric anlage is first morphologically recog-
nizable at around stage 23 as a distortion of the interme-
diate mesoderm as cells change shape, becoming more
columnar. These condensed cells distend the overlying
epidermis, forming the pronephric swelling. Cells within
this condensation later epithelialize and form the pro-
nephric tubules (Goodrich, 1930; Armstrong, 1932; Vize
et al., 1995, 1997). The reduced pronephroi of xWT1-
injected embryos could arise from a smaller than normal
pronephric anlage, or they could result from a failure of
tubule morphogenesis within a normal anlage. Because
antibody 3G8 stains only the lumenal surface of the
pronephric tubules (Vize et al., 1995), the phenotype
observed in whole-mount could represent a simple failure
to epithelialize and form a lumen within an otherwise
normal pronephric anlage.
In order to explore the morphology of the phenotype
resulting from xWT1 overexpression, injected embryos
were examined using confocal scanning laser microscopy.
Optical sagittal (Figs. 3A and 3B) and transverse (Figs. 3C
and 3D) sections revealed a normal tubular epithelium
surrounding the pronephric tubule complex in these em-
bryos. However, the volume of 3G8 stained tubules was
significantly reduced on injected sides (Figs. 3B and 3D)
compared to uninjected sides (Figs. 3A and 3C). The optical
FIG. 1. The pronephric index. The index quantifies the extent of pronephric development by comparing the left and right pronephroi
within an embryo (based upon the pattern of antibody 3G8 staining at stage 37/38). (A and B) Opposite sides of an embryo injected on one
side with 1 ng of b-galactosidase mRNA and stained with antibody 3G8 to detect pronephric tubules (arrow in A indicates staining).
Staining for b-galactosidase activity (light blue/green in B) indicates that injection into the C3 and D3 blastomeres has targeted mRNA to
the pronephric region of the injected side (B). (a9 and b9). Enlarged, diagrammatic representation of the pronephroi in A and B. For
quantification of pronephric development, each pronephros in an embryo is scored by assigning one point for each of the numbered tubule
components in the figure (a9 and b9). A normal Xenopus pronephros has five components: one vertical tube, one horizontal tube, and three
attached branches (see Vize et al., 1995), so a score of 5 is assigned to a normal pronephros; 0 indicates no pronephros. The pronephric index
(PNI) is then expressed as the difference between the two sides. PNI 5 0 indicates two identical pronephroi; PNI 5 5 indicates a normal
pronephros on one side and no pronephros on the other. The embryo shown in A and B has a pronephric index of 0, indicating that injection
of b-galactosidase mRNA has no effect on pronephric development.
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transverse sections also revealed considerably reduced pro-
nephric swellings on injected sides, as judged by a less
obvious bulge in overlying epidermis and reduced compres-
sion of the underlying splanchnic lateral plate and endoder-
mal mass, compared to uninjected sides of the same em-
bryos (Figs. 3C and 3D).
In order to better characterize the pronephric tubule
epithelia of experimental embryos, injected embryos were
stained with propidium iodide and confocal microscopy
was used to visualize nuclei. This analysis revealed fewer
cells within xWT1 mRNA-injected pronephroi compared to
uninjected controls (Figs. 3E and 3F). This observation
suggests that the reduction in size of the pronephric tubules
results from a failure to specify an anlage of appropriate
size, rather than a failure of epithelialization within a
properly developed anlage.
Overexpression of xWT1 Disrupts Very Early
Stages of Pronephric Specification
Endogenous xWT1 expression commences around stage
20, shortly before the pronephric tubule anlage segregates
from the intermediate mesoderm (Carroll and Vize, 1996;
Nieuwkoop and Faber, 1994). To determine if the injected
xWT1 message was present during the developmental pe-
riod when the pronephros is patterned and begins to differ-
entiate, the stability of injected xWT1 mRNA was exam-
ined. RNA was injected into blastomeres C3 and D3 of
32-cell stage embryos as described above. Subsequent RT–
PCR using primers specific for the injected message re-
vealed that the xWT1 mRNA was present in injected
embryos until at least stage 30 (Fig. 4), indicating that the
injected xWT1 message is stable throughout pronephric
patterning and differentiation (Vize et al., 1995; Nieuwkoop
FIG. 2. Injection of xWT1-KTS mRNA inhibits the development of the pronephric tubules. Antibody 3G8 was used to detect the
pronephric tubules (dark purple in all panels), and X-Gal was used to detect the b-galactosidase (light blue/green in B and D). (A and B)
Opposite sides of an experimental embryo injected with 1 ng of xWT1-KTS mRNA (10.25 ng of b-galactosidase mRNA). The uninjected
side (A) is normal, while all distal branches of the collecting tubule are absent on the injected side (B). The diameter and length of the
remaining common tubule and collecting tubule are also reduced on the injected side (B) compared to the uninjected side (A). The control,
uninjected pronephros (diagrammed in a9) is normal and is assigned 5 points; the pronephros on the injected side of the same embryo
(diagrammed in b9) is lacking all distal branches of the connecting tubule and is assigned only 2 points. The resulting PNI for this embryo
is 3, indicating a significant inhibition of pronephric development (see Table 1). (C and D) Opposite sides of a different embryo injected with
1 ng of xWT1-KTS mRNA (10.25 ng of b-galactosidase mRNA) displaying a more severe phenotype. The uninjected pronephros (C) is
normal and is assigned 5 points (c9). However, the pronephros on the injected side (D) consists only of a single unbranched tubule and is
assigned only 1 point (d9). The PNI for this embryo is 4, again indicating inhibition of pronephric development. While the morphology of
the uninjected pronephros is normal (c9), note that it is somewhat swollen compared to normal, likely the result of hypertrophy in order
to compensate for loss of pronephric function on the injected side (Fox, 1956; Howland, 1921). The reduction in the amount of
b-galactosidase staining in injected embryos (B and D) compared to the embryo shown in Fig. 1 is consistent with the amount of
b-galactosidase mRNA injected: 0.25 ng co-injected with xWT1 in this figure compared to 1 ng when b-galactosidase was injected alone in
Fig. 1.
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and Faber, 1994). As such, it was possible that exogenous
xWT1 inhibited pronephric tubule development at very
early stages. It was also possible that exogenous xWT1 was
acting much later, at a time when endogenous xWT1 is also
expressed. In order to address this issue, we examined
xWT1-injected embryos for expression of a very early mo-
lecular marker for the developing pronephros, Xlim-1 (Taira
et al., 1994).
Embryos were injected at the 32-cell stage with either
xWT1-KTS mRNA (plus b-galactosidase) or with b-galact-
FIG. 3. Confocal microscopic analysis of the xWT1 overexpression phenotype. (A and B) High-magnification confocal optical sagittal
sections through the pronephroi of an embryo injected on one side with xWT1-KTS mRNA. The embryo is stained with 3G8 using a
rhodamine-conjugated secondary antibody, and the cell boundaries of tubular epithelial cells (indicated by arrows) are visible due to
autofluorescence of yolk platelets (see Wallingford et al., 1997). A single layer of pronephric epithelial cells surrounds the pronephric lumen
on both uninjected (A) and injected (B) sides of the embryos. However, the pronephric tubule epithelial complex on the injected side (B) is
significantly smaller than that on the uninjected side (A). (C and D) Confocal optical transverse sections of an embryo injected with
xWT1-KTS mRNA. The pronephros on the injected side (D) is significantly reduced compared to that on the uninjected side (C). The ventral
portion of the somite (S), the notochord (N), and the lateral plate (lp) are normal on both sides. The glomus (G) appears to be highly
disorganized on the injected side of the embryo (D), consistent with the hypothesis that signals from the tubules are required for the
formation of the glomus (Fales, 1935). (E and F) Confocal optical transverse sections of an embryo injected on one side with xWT1-KTS
mRNA and stained with propidium iodide to visualize nuclei. The pronephric tubule epithelium on the uninjected side (E, arrows) is
normal, while the tubule epithelium on the injected side (F, arrow) is significantly smaller and contains fewer cells.
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osidase mRNA alone. Injected embryos were then reared to
tailbud stages (stage 20), and in situ hybridization was used
to examine expression of Xlim-1. Injection of 1.25 ng of
b-galactosidase had no effect on the expression pattern of
Xlim-1 (Figs. 5A and 5B). On the other hand, injection of 1
ng of xWT1 mRNA resulted in dramatic reduction in
Xlim-1 expression on the injected sides of experimental
embryos (Figs. 5C and 5D). This result suggests that preco-
cious expression of xWT1 inhibits the early stages of
pronephric patterning, acting well before the onset of en-
dogenous xWT1 expression.
DISCUSSION
The manipulability of the Xenopus embryo and the
simplicity of its pronephroi make this system very appeal-
ing for the study of early events in kidney development
(Vize et al., 1997). The first experiments described here
define the consistency with which Xenopus pronephroi
develop and a simple index has been generated by which the
extent of pronephric development following experimental
manipulation can be quantified. This system has then been
used to examine the activity of xWT1 in pronephric devel-
opment. The results presented indicate a role for WT1 genes
in the downregulation of tubule-specific gene expression
and highlight interesting similarities and differences be-
tween pronephric and metanephric development.
Mode of Action of Ectopic xWT1
When xWT1 was ectopically expressed in the pronephric
tubule primordia, it acted at a very early stage to inhibit
tubule specification (Figs. 2 and 5). WT1 is a powerful
transcriptional repressor (Madden et al., 1991), and as WT1
inhibits the expression of Pax-2 (Ryan et al., 1995), Pax-2
inhibition could in theory be responsible for the xWT1
overexpression phenotype. However, this cannot be the
case, as pronephric expression of Xenopus Pax-2 does not
commence until stage 21 (Heller and Brandli et al., 1997),
and xWT1-injected embryos display marked defects in pro-
nephric development prior to stage 20 (Fig. 5).
It is nonetheless quite likely that ectopic xWT1 acts as a
transcriptional repressor of target genes other than Pax-2,
and the repression of genes required for tubule development
results in the formation of a smaller pronephric anlage and
in turn a smaller pronephric tubule complex. The finding
that both xWT1 1 KTS and xWT1 2 KTS inhibit tubule
development (Table 1) is consistent with this hypothesis, as
both splice forms can act as transcriptional repressors in
vitro (Ryan et al., 1995; Wang et al., 1995). On the other
hand, WT1 has also been shown to bind mRNA and may
downregulate gene expression posttranscriptionally
(Kennedy et al., 1996; Caricasole et al., 1996; Larsson et al.,
1995), so it is also possible that this activity, rather than
direct transcriptional regulation, is responsible for the ob-
served phenotype.
A Role for WT1 in the Inhibition of Tubule-
Specific Gene Expression
Ectopic expression of xWT1 in the tubule primordia
restricted the formation of the pronephric tubule anlage,
resulting in a smaller anlage, and thus a reduction in tubule
size and complexity compared to control pronephroi. This
result introduces the intriguing possibility that the role of
endogenous WT1 may be to inhibit expression of genes
involved in the response to kidney inducing signals. Con-
sistent with this hypothesis is the finding that murine WT1
binds to and represses the Pax-2 promoter, and the onset of
WT1 expression in the metanephros correlates well with
the downregulation of Pax-2 expression (Ryan et al., 1995).
Such downregulation is essential to proper metanephric
tubule development as continued expression of Pax-2 re-
sults in severe defects in metanephric tubule development
(Dressler et al., 1993).
A Role for WT1 in the Development of the
Vascular Component of the Kidney
In mammals, WT1 is expressed in the condensed meta-
nephric mesenchyme during the early stages of kidney
development, and this expression is required for meta-
nephric tubule differentiation (Kreidberg et al., 1993). At
later stages, mammalian WT1 expression is restricted
solely to the developing glomeruli (Mundlos et al., 1993;
Armstrong et al., 1992), suggesting an additional role for
this gene in the development of the vascular component
of the nephron. Consistent with this hypothesis, many
humans with mutations in WT1 exhibit defective vascu-
FIG. 4. Injected xWT1 message persists throughout pronephric
development. RT–PCR using primers which specifically amplify
the injected message indicates that the injected xWT1 mRNA
remains stable until at least stage 30, by which time the pronephros
is well differentiated. EF1a was also amplified as a loading control.
Numbers at the top of the figure indicate developmental stages; 1,
injected embryos; 2, uninjected embryos; 2RT, no reverse tran-
scriptase; plasmid, PCR performed on 1 ng of xWT1 plasmid as a
positive control. The small amount of signal in the stage 10.5
uninjected sample is probably due to spillage during gel loading.
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lar development in the glomeruli (Pelletier et al., 1991;
Denys et al., 1967; Drash et al., 1970). Interestingly, the
expression of xWT1 is restricted to the vascular compo-
nent of the kidney throughout pronephric development;
it is never expressed at detectable levels in the pronephric
tubules (Carroll and Vize, 1996).
In light of the xWT1 expression pattern, the finding that
xWT1 expression inhibits pronephric tubule development
suggests that the normal role of xWT1 in the developing
pronephros may be to restrict the fate of these cells,
preventing Pax-2 expression and thus tubule specification,
reserving them for the later formation of the glomus. The
timing of xWT1 expression is consistent with this hypoth-
esis. xWT1 transcription commences in the cells of the
presumptive glomus concomitant with the onset of tubule
differentiation in adjacent cells (about stage 20). However,
the glomus will not differentiate until much later (about
stage 27). xWT1 may be necessary to inhibit tubule differ-
entiation in the pool of cells which are reserved for the later
formation of the glomus over this time period. The fact that
WT1 inhibits the expression of several genes involved in
tubule development (discussed above) is also consistent
with this hypothesis.
The Pronephros and the Metanephros: Similarities
and Differences
The results presented here underscore both important
differences and similarities between pronephric develop-
ment and metanephric development. For example, the
finding that endogenous xWT1 is not expressed in proneph-
ric tubules (Carroll and Vize, 1996) strongly argues that
WT1 is dispensable for pronephric tubule differentiation;
and consistent with this hypothesis, the more cranial
(pronephros-like) mesonephric tubules of mice develop nor-
mally in the absence of functional WT1 (Sainio et al., 1997).
However, WT1 activity is clearly required for the develop-
ment of the caudal mesonephric and metanephric tubules
(Kreidberg et al., 1993). These results may highlight an
important difference in how pronephric and metanephric
tubules develop. During metanephric development, mesen-
chymal cells of the nephrogenic cord proliferate to form the
metanephric blastema, which then condenses and epitheli-
alizes to form tubules (Saxen, 1987), and WT1 is required for
this process (Kreidberg et al., 1993). During pronephric
development, on the other hand, the pronephric anlage
forms as cells in the intermediate mesoderm segregate by
cell shape changes, and this anlage then epithelializes to
FIG. 5. xWT1 expression disrupts early events in pronephric specification. Expression of Xlim-1, an early molecular marker for the
pronephros, was detected at stage 20 by in situ hybridization (dark purple in all panels) and b-galactosidase was detected with X-Gal (light
blue/green in B and D). (A and B) Opposite sides of an embryo injected on one side with of b-galactosidase mRNA. Xlim-1 expression is
strong on both the uninjected (A) and injected (B) sides. (C and D) Opposite sides of an embryo injected on one side with xWT1-KTS
(1b-galactosidase mRNA). Xlim-1 expression is normal on the uninjected side (C), while expression is dramatically reduced on the injected
side (D). The result indicates that ectopic xWT1 mRNA expression inhibits pronephric development at a very early stage.
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form tubules (Vize et al., 1997), a process which does not
appear to require WT1 expression.
On the other hand, the vascular components of both
pronephroi and metanephroi apparently utilize very similar
genetic pathways to restrict cell fate during development
despite their vastly different architecture. Furthermore,
although the requirements for WT1 are different in the
development of different kidney forms, it appears that the
activity of this protein as a negative regulator of tubule-
specific gene expression is the same in all cases, downregu-
lating expression of specific genes in the tubules in order to
allow differentiation to proceed and downregulating expres-
sion of specific genes in the vascular components in order to
restrict their fate.
ACKNOWLEDGMENTS
The authors thank Douglas Melton for encouragement and
support throughout the course of this work and for performing the
independent microinjection experiments. We thank Michael Da-
nilchik for the use of the confocal microscope (supported by NSF
IBN 9396063) and for invaluable technical advice. We thank
Matthew Grow and Eric Small for critical reading of the manu-
script. This research was supported by Texas ARP Grant 187 (P.V.),
NSF IBN9630621 (P.V.), and NIH Training Grant T-32
HD07296-GT (T.C.).
REFERENCES
Armstrong, P. B. (1932). The embryonic origin of function in the
pronephros through differentiation and parencyma–vascular as-
sociation. Am. J. Anat. 51, 157–188.
Armstrong, J. F., Pritchard-Jones, K., Bickmore, W. A., Hastie,
N. D., and Bard, J. B. L. (1992). The expression of the Wilms’
tumor gene WT1 in the developing mammalian embryo. Mech.
Dev. 40, 85–97.
Balinsky, B. I. (1970). “An Introduction to Embryology.” Saunders,
Philadelphia.
Burns, R. K. (1955). Urogenital system. In “Analysis of Develop-
ment” B. H. Willier, P. A. Weiss, and V. Hamburger, Eds.).
Saunders, Philadelphia.
Caricasole, A., Duarte, A., Larsson, A., Hastie, N., Little, M.,
Holmes, G., Todorov, I., and Ward, A. (1996). RNA binding by the
Wilms’ tumor suppressor zinc finger proteins. Proc. Natl. Acad.
Sci. USA 93, 7562–7566.
Carroll, T. J., and Vize, P. D. (1996). The Wilms’ tumor suppressor
gene is involved in the development of disparate kidney forms:
Evidence from expression in the Xenopus pronephros. Dev. Dyn.
206, 131–138.
Coppes, M. J., Campbell, C. E., and Williams, B. R. G. (1995).
“Wilms’ Tumor: Clinical and Molecular Characterization.” Lan-
des, Austin, TX.
Dale, L., and Slack, J. M. W. (1987). Fate map of the 32-cell stage of
Xenopus. Development 99, 527–551.
Denys, P., Malvaux, P., van den Berghe, H., Tanghe, W., and
Proesmans, W. (1967). Association d’un syndrome anato-
mopathologique de pseudohermaphrodisme masculin, d’un tu-
meur de Wilms, d’une nephropathie parenchymateuse et d’une
mosaicisme XX/XY. Arch. Fr. Pediatr. 24, 729–739.
Drash, A., Sherman, F., Hartman, W. H., and Blizzard, R. M. (1970).
A syndrome of pseudohermaphrodism, Wilms’ tumor, hyperten-
sion, and degenerative renal disease. J. Pediatr. 76, 585–593.
Dressler, G. R., Wilkinson, J. E., Rothenpieler, U. W., Patterson,
L. T., William-Simons, L., and Westhal, H. (1993). Deregulation
of Pax-2 expression in transgenic mice generates severe kidney
abnormalities. Nature 362, 65–67.
Drummond, I., Madden, S., Rohwer-Nutter, P., Bell, G. I.,
Sukhatme, V. P., and Rauscher, F. J. (1992). Repression of the
insulin-like growth factor II gene by the Wilms’ tumor suppres-
sor WT1. Science 257, 674–678.
Englert, C., Hou, X., Maheswaran, S., Bennett, P., Ngwu, C., Re, G.,
Garvin, A., Rosner, M., and Haber, D. (1995). WT1 suppresses
synthesis of the epidermal growth factor receptor. EMBO J. 14,
4462–4675.
Fales, D. E. (1935). Experiments on the development of the prone-
phros of Ambystoma punctatum. J. Exp. Zool. 72, 147–173.
Field, H. H. (1891). The development of the pronephros and the
segmental duct in Amphibia. Bull. Mus. Comp. Zool. Harv. 21,
201–240.
Fox, H. (1963). The amphibian pronephros. Quart. Rev. Biol. 38,
1–25.
Fox, H. (1956). Compensation in the remaining pronephros of
Triturus after unilateral preonephrectomy. J. Embryol. Exp.
Morph. 4, 139–151.
Goodrich, E. S. (1930). “Studies on the Structure and Development
of Vertebrates.” Macmillan, London. [Reprinted by the Univer-
sity of Chicago Press, Chicago, 1986]
Harland, R. (1991). In situ hybridization: An improved method for
Xenopus embryos. In “Methods in Cell Biology” (B. K. Kay and
H. B. Peng, Eds.), Vol. 36, pp. 685–695. Academic Press, San
Diego.
Heller, N., and Brandli, A. W. (1997). Xenopus Pax-2 displays
multiple splice forms during embryogenesis and pronephric
kidney development. Mech. Dev. 69, 83–104.
Howland, R. B. (1921). Experiments of the effects of removal of the
pronephros of amphibian embryos. J. Exp. Zool. 32, 355–395.
Kennedy, D., Ramsdale, T., Mattick, J., and Little, M. (1996). An
RNA recognition motif in Wilms’ tumour protein (WT1) revealed
by structural modelling. Nat. Genet. 12, 329–331.
Kintner, C., and Brockes, J. P. (1984). Monoclonal antibodies
identify blastemal cells derived from differentiating muscle in
newt limb regeneration. Nature 308, 67–69.
Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J.,
and Jaenisch, R. (1993). WT-1 is required for early kidney
development. Cell 74, 679–691.
Krieg, P. A., and Melton, D. A. (1984). Functional messenger RNAs
are produced by SP6 in vitro transcription of cloned cDNAs.
Nucleic Acids Res. 12, 7057–7070.
Larsson, S. H., Charlieu, J. P., Miyagawa, K., Engelkamp, D.,
Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and
Hastie, N. D. (1995). Subnuclear localization of WT1 in splicing
or transcription factor domains is regulated by alternative splic-
ing. Cell 81, 391–401.
Madden, S., Cook, D. M., Morris, J., Gashler, A., Sukhatme, V. P.,
and Rauscher, F. J. (1991). Transcription repression mediated by
the WT1 Wilms tumor gene product. Science 253, 1550–1553.
Mu¨ller, J. (1829). Uber die Wolffschen ko¨rper bei den embryonen
der fro¨sche und kro¨ten. Arch. Anat. Phys. Jhrg., 65–70. [Transla-
tion in Adelman, H. B. (1966), “Marcello Malpighi and the
Evolution of Embryology.” Cornell Univ. Press, Ithaca, NY]
111xWT1 Inhibits Kidney Development in X. laevis
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
Mundlos, S., Pelletiaer, J., Darveau, A., Bachmann, M., Win-
terspacht, A., and Zabel, B. (1993). Nuclear localization of the
protein encoded by the Wilms’ tumor gene WT1 in embryonic
and adult tissues. Development 119, 1329–1341.
Nakamura, H., Tashiro, K., Nakamura, T., and Shiokawa, K. (1995).
Molecular cloning of Xenopus HGF cDNA and its expression
studies in Xenopus early embryogenesis. Mech. Devel. 49, 123–
131.
Nieuwkoop, P. D., and Faber, J. (1994). “Normal Table of Xenopus
laevis (Daudin),” 3rd ed. Garland, New York.
Pelletier, J., Schalling, M., Buckler, A. J., Rogers, A., Haber, D. A.,
and Housman, D. (1991a). Expression of the Wilms’ tumor gene
WT1 in the murine urogenital system. Genet. Dev. 5, 1345–1356.
Pelletier, J., Bruening, W., Kashtan, C., Mauer, S., Manivel, J.,
Striegel, J., Houghton, D., Junien, C., Habib, R., Fouser, L., Fine,
R., Silvermn, B., Haber, D., and Housman, D. (1991b). Germiline
mutations in teh Wilms’ tumor suppressor gene are associated
with abnormal urogenital development in Denys–Drash syn-
drome. Cell 67, 437–447.
Peng, H. B. (1991). Solutions and protocols. In “Methods in Cell
Biology” (B. K. Kay and H. B. Peng, Eds.), Vol. 36, pp. 657–662.
Academic Press, San Diego.
Ryan, G., Steele-Perkins, V., Morris, J., Rauscher, F., and Dressler,
G. R. (1995). Repression of Pax-2 by WT1 during normal kidney
development. Development 121, 867–875.
Sanio, K., Hellstedt, P., Kreidberg, J. A., Saxen, L., and Sariola, H.
(1997). Differential regulation of two sets of mesonephric tubules
by WT1. Development 124, 1293–1299.
Saxe´n, L. (1987). “Organogenesis of the Kidney.” Cambridge Univ.
Press, Cambridge.
Taira, M., Otani, H., Jamrich, M., and Dawid, I. (1994). Expression
of the Lim class homeobox gene Xlim-1 in the pronephros and
CNS cell linages of Xenopus embryos is affected by retinoic
acidand exogastrulation. Development 120, 1525–1536.
Vize, P., Melton, D., Hemmati-Brivanlou, A., and Harland, R.
(1991). Assays for gene function in developing Xenopus embryos.
Methods Cell Biol. 36, 367–387.
Vize, P., Jones, E., and Pfister, R. (1995). Development of the
Xenopus pronephros. Dev. Biol. 171, 531–540.
Vize, P., Seufert, D. W., Carroll, T. J., and Wallingford, J. B. (1997).
Model systems for the study of kidney development: Use of the
pronephros in the analysis of organ induction and patterning.
Dev. Biol. 188, 189–204.
Wallingford, J., Sater, A., Uzman, J. A., and Danilchik, M. (1997).
Inhibition of morphogenetic movement during Xenopus gastru-
lation by injected sulfatase: Implications for anteroposterior and
dorsoventral axis formation. Dev. Biol. 187, 224–235.
Wang, Z-Y., Qiu, Q-Q., Huang, J., Gurrieri, M., and Deuel, T.
(1995). Products of alternatively spliced transcripts of the Wilms’
tumor suppressor gene WT1 have altered DNA binding specific-
ity and regulate transcription in different ways. Oncogene 10,
415–122.
Received for publication May 15, 1998
Accepted June 17, 1998
112 Wallingford, Carroll, and Vize
Copyright © 1998 by Academic Press. All rights of reproduction in any form reserved.
